Diagnostic News and Research

RSS

USC School of Medicine to host the first World Congress of Ultrasound in Medical Education

Ultrasound is a valuable tool that allows doctors to diagnose and treat patients quickly and accurately. It's been around for decades, but there has been revolutionary change in the technology in recent years, making the machines smaller, cheaper and smarter.

21 Jan 2011

BOKA Powell releases new images of Methodist Hospital for Surgery in Texas

BOKA Powell released new images today of the completed Methodist Hospital for Surgery in Addison, Texas, a dedicated surgical hospital which opened last month.

21 Jan 2011

OriGene releases 1,500 mouse monoclonal antibodies

OriGene Technologies, Inc. has recently achieved a significant milestone in its quest for developing an assay for every human protein through the release of 1,500 mouse monoclonal antibodies under the TrueMAB brand. Each TrueMAB antibody is specifically developed with full-length human proteins produced in HEK293T cells and validated for critical research and diagnostic needs requiring improved antibody sensitivity and specificity.

21 Jan 2011

Researchers believe driver mutations promote development, growth of prostate cancer

Prostate cancer is known to occur typically in older men. Yet some patients are younger than 50 years at the time of diagnosis. Scientists assume that these cases might be the key to understanding the biology of this disease. Early prostate cancer might be a subtype which is characterized by a relatively small number of genetic modifications.

21 Jan 2011

New gene test can predict tumor spread in bladder cancer patients

Cancer scientists have designed the first molecular test to predict which bladder cancer patients may have cancer involvement in their lymph nodes at the time of surgery-which could help doctors determine which patients are good candidates for pre-surgical, or neo-adjuvant, chemotherapy.

21 Jan 2011

Ultrasound practice accreditation is now available in Fetal Echocardiography: AUSM

The American Institute of Ultrasound in Medicine announced today that ultrasound practice accreditation is now available in Fetal Echocardiography. The program sets the standard for care in fetal echocardiography and builds on the development of AIUM guidelines aimed at fostering its safe and effective use.

20 Jan 2011

Study demonstrates prognostic value of DiagnoCure's Previstage GCC Colorectal Cancer Staging Test

DiagnoCure Inc., a life sciences company commercializing high‐value cancer diagnostic tests and delivering lab services, today announced positive initial results of a multi-center clinical study of 241 stage II colon cancer patients, a population categorized as low risk by traditional methods yet with an average recurrence rate of 20%.

20 Jan 2011

Grayscale IVUS and VH IVUS tissue characterization software help accurate assessment of blockage risk

Volcano Corporation today announced the publication of results from the PROSPECT (Providing Regional Observations to Study Predictors of Events in the Coronary Tree) study in The New England Journal of Medicine showing that grayscale intravascular ultrasound (IVUS) and Volcano's proprietary VH® IVUS tissue characterization software enable physicians to more accurately assess the risk of individual blockages than the use of the current standard-of-care-- angiographic imaging-- alone.

20 Jan 2011

Meridian Bioscience first quarter net sales decrease 12% to $37.3 million

Net sales for the first quarter of fiscal 2011 were $37,263,000 as compared to $42,457,000 for the same period of the prior fiscal year, a decrease of 12%. Net earnings for the first quarter of fiscal 2011 were $6,025,000, or $0.15 per diluted share, both decreases of 32% from the first quarter of fiscal 2010. Diluted common shares outstanding for the first quarter of fiscal 2011 and 2010 were 41,294,000 and 41,185,000, respectively.

20 Jan 2011

OSC and RINCH offer support to speed discovery techniques of childhood diseases

Worried about her high fever and severe abdominal pain, a young couple rushed their baby daughter to the emergency department of Nationwide Children's Hospital. Physicians there found a lump in her belly, and, after examining X-rays and blood work, confirmed the parents' worst fear: their 18-month-old little girl had neuroblastoma, a rare pediatric cancer that involves the adrenal glands.

20 Jan 2011

FDA unveils plan to improve marketing and review process for medical devices

The U.S. Food and Drug Administration today unveiled a plan containing 25 actions it intends to implement during 2011 to improve the most common path to market for medical devices.

20 Jan 2011

SCAI publishes guiding principles for development of radiation safety programs in cardiac catheterization laboratories

Today the Society for Cardiovascular Angiography and Interventions published guiding principles and best practices for the development of radiation safety programs in cardiac catheterization laboratories.

20 Jan 2011

Singapore study finds video game addiction exists globally

A new study by an international research team -- including an Iowa State University psychologist -- found further evidence that video game "addiction" exists globally and that greater amounts of gaming, lower social competence and greater impulsivity were risk factors for becoming pathological gamers.

20 Jan 2011

Autism Speaks Autism Treatment Network adds 17 sites in Canada and the U.S

Autism Speaks and Autism Speaks Canada who together form North America's largest autism science and advocacy organization, is pleased to announce the expansion of its Autism Treatment Network to include 17 leading children's hospitals and academic medical centers in the Canada and the U.S.

20 Jan 2011

Children's Hospital Los Angeles becomes only Autism Treatment Network site in California

Following a competitive application process, Michele D. Kipke, PhD, Vice Chair of Research for the Department of Pediatrics, Children's Hospital Los Angeles, was awarded a $420,000 grant which will allow the hospital to become part of the Autism Treatment Network (ATN) as an ATN Center of Clinical Excellence.

20 Jan 2011

National Jewish Health issued method patent for desensitizing B cells

National Jewish Health has been issued a US patent claiming a method to desensitize B cells by inactivating antigen receptors on their surfaces. The method, discovered by John Cambier, PhD, Chairman of the Integrated Department of Immunology at National Jewish Health, holds promise for treatment of B-cell mediated diseases, such as lymphoma and leukemia, rheumatoid arthritis, lupus and rejection of organ transplants.

19 Jan 2011

Dextran-coated onto iron oxide nanoparticles can detect cholera toxin: Study

A complex sugar may someday become one of the most effective weapons to stop the spread of cholera, a disease that has claimed thousands of lives in Haiti since the devastating earthquake last year.

19 Jan 2011

Only half of adolescents affected with severely impairing mental disorders receive treatment

A recent study by Merikangas and colleagues published in the January 2011 issue of the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP) shows that only half of adolescents that are affected with severely impairing mental disorders ever receive treatment for their disorders.

19 Jan 2011

Concomitant physical symptoms in patients with depression and anxiety associated with poorer prognosis

This study, published in the last 2010 issue of Psychotherapy and Psychosomatics, indicate that concomitant physical symptoms in patients with depression and anxiety are associated with a poorer prognosis of symptoms of depression and anxiety and that it might prove worthwhile to pay attention to the role of multiple physical symptoms in the process of tailoring interventions to meet the needs of depressed and anxious patients in primary care.

19 Jan 2011

RG7204 Phase III study shows significant survival benefit in patients with metastatic melanoma

Genentech, a member of the Roche Group, today announced that BRIM3, a Phase III clinical study of RG7204, met its co-primary endpoints showing a significant survival benefit in people with previously untreated BRAF V600 mutation-positive metastatic melanoma.

19 Jan 2011

Diagnostic News and Research

USC School of Medicine to host the first World Congress of Ultrasound in Medical Education

BOKA Powell releases new images of Methodist Hospital for Surgery in Texas

OriGene releases 1,500 mouse monoclonal antibodies

Researchers believe driver mutations promote development, growth of prostate cancer

New gene test can predict tumor spread in bladder cancer patients

Ultrasound practice accreditation is now available in Fetal Echocardiography: AUSM

Study demonstrates prognostic value of DiagnoCure's Previstage GCC Colorectal Cancer Staging Test

Grayscale IVUS and VH IVUS tissue characterization software help accurate assessment of blockage risk

Meridian Bioscience first quarter net sales decrease 12% to $37.3 million

OSC and RINCH offer support to speed discovery techniques of childhood diseases

FDA unveils plan to improve marketing and review process for medical devices

SCAI publishes guiding principles for development of radiation safety programs in cardiac catheterization laboratories

Singapore study finds video game addiction exists globally

Autism Speaks Autism Treatment Network adds 17 sites in Canada and the U.S

Children's Hospital Los Angeles becomes only Autism Treatment Network site in California

National Jewish Health issued method patent for desensitizing B cells

Dextran-coated onto iron oxide nanoparticles can detect cholera toxin: Study

Only half of adolescents affected with severely impairing mental disorders receive treatment

Concomitant physical symptoms in patients with depression and anxiety associated with poorer prognosis

RG7204 Phase III study shows significant survival benefit in patients with metastatic melanoma

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News